Llwytho...
Cancer-testis antigens as biomarkers for Merkel cell carcinoma: Pitfalls and opportunities
BACKGROUND: The prognosis and treatment options for metastatic Merkel cell carcinoma (MCC) are poor. The immune-privileged status of cancer-testis (CT) antigens imparts tumor specificity, making them ideal candidates for targeted immunotherapy. We investigate the usefulness of the CT antigens SPA17...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Cutan Pathol |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8130841/ https://ncbi.nlm.nih.gov/pubmed/31218705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cup.13528 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|